Genetic factors may influence an individual's susceptibility to the carcinogenic effects of PHIP. Variations in genes encoding for enzymes involved in the metabolism of PHIP, such as cytochrome P450 enzymes and N-acetyltransferases, can affect how PHIP is processed in the body. Individuals with certain genetic polymorphisms may metabolize PHIP more efficiently into its reactive forms, potentially increasing their cancer risk.
